NEW YORK (Reuters Health) – Nine times out of 10, patients admitted to a U.S. hospital for acute exacerbation of chronic obstructive pulmonary disease (COPD) are treated initially…
Program Survey Please click here to participate in our 15-second survey to provide feedback on this program. Program Overview As clinicians, we know that taking folic acid prior…
NEW YORK (Reuters Health) – The novel antiarrhythmic agent vernakalant is a safe and effective agent for pharmacologic conversion of recent-onset atrial fibrillation (AF) in hemodynamically stable patients,…
NEW YORK (Reuters Health) – Inhaled anticholinergics may increase the risk of community-acquired pneumonia in asthma patients, results of a Spanish case-control study suggest. The findings, published online…
NEW YORK (Reuters Health) – More than half of elderly patients who come out of the hospital after pneumonia either die within a year or get readmitted for…
NEW YORK (Reuters Health) – For locally advanced and metastatic prostate cancer, the best timing and duration of androgen-deprivation therapy (ADT) is unclear. Now, a systematic review suggests…
NEW YORK (Reuters Health) – Pretreating antibiotic-resistant Helicobacter pylori with a mucolytic that destroys bacterial biofilm can eradicate infection in many cases, Italian research shows. “A standard rescue…
NEW YORK (Reuters Health) – Balloon angioplasty, drug-eluting stents, and bare metal stents appear to be equally effective at reducing death or myocardial infarction (MI) over a year’s…
NEW YORK (Reuters Health) – In patients with extensively drug-resistant tuberculosis (XDR TB), adding a later-generation fluoroquinolone to the treatment regimen may improve outcomes, even when drug-susceptibility testing…
NEW YORK (Reuters Health) – Patients with relapsing mild-to-moderate ulcerative colitis (UC) on immunosuppressive therapy may benefit from the addition of a high-potency probiotic mixture (VSL#3; VSL Pharmaceuticals…
